Anastrozole
Anastrozole is an aromatase inhibitor used to treat hormone receptor-positive breast cancer in postmenopausal women — including early, locally advanced, and metastatic disease.
🧬 Where this information comes from Click to expand
The clinical label records used on this page are FDA-filed Structured Product Labeling (SPL) retrieved through openFDA. We identified 40 clinical label sets within the page’s selected clinical scope after exact ingredient or ingredient-combination matching and applicable route/form matching. Forms, routes, brands, labelers, strengths, and NDC product-record counts are built separately from matching FDA National Drug Code Directory records. The linked DailyMed document is a representative official source for verification, not the page’s only clinical source. View the linked label on DailyMed →
📖 Anastrozole: Patient Information Guide
A plain-language walkthrough of Anastrozole — what it treats, how it works, how it’s taken, side effects, warnings and interactions. Tap any section to expand it.
🎯What it's used for▾
Anastrozole is an aromatase inhibitor approved for treating hormone receptor-positive breast cancer in postmenopausal women across several clinical settings.
- Early breast cancer (adjuvant): Anastrozole and Arimidex (tablet) are each approved for postmenopausal women with hormone receptor-positive early breast cancer following primary treatment such as surgery.
- Locally advanced or metastatic breast cancer (first-line): Anastrozole and Arimidex tablets are approved as an initial treatment for postmenopausal women with hormone receptor-positive or hormone receptor-unknown locally advanced or metastatic breast cancer.
- Advanced breast cancer (second-line): Anastrozole and Arimidex tablets are approved for postmenopausal women with advanced breast cancer that progressed after tamoxifen therapy. Women who were estrogen receptor-negative or did not respond to tamoxifen rarely responded to anastrozole.
⚙️How it works▾
In postmenopausal women, the body makes estrogen mainly through an enzyme called aromatase, which converts other hormones (androgens) into estradiol. Many breast cancers need estrogen to grow. Anastrozole selectively blocks the aromatase enzyme, dramatically lowering estrogen levels throughout the body — including in cancer tissue itself — which can slow or stop the growth of estrogen-sensitive tumors.
Anastrozole does not affect the production of cortisol or aldosterone (the body's stress and fluid-balance hormones), so no hormone replacement is needed while you take it. It also has no direct effect on thyroid hormone levels.
💊How it's taken▾
Anastrozole tablets are taken once daily by mouth and can be taken with or without food — though food may slightly delay how quickly it is absorbed. For advanced breast cancer, treatment continues until the cancer progresses; for early breast cancer, your prescriber will determine the duration (in clinical trials, treatment was given for five years).
- No dose adjustment is needed for kidney impairment or older age.
- No dose adjustment is needed for mild-to-moderate liver disease; severe liver impairment has not been studied.
- Always follow your prescriber's instructions for your specific situation.
🤒Side effects — in detail▾
The most commonly reported side effects of anastrozole include:
- Hot flashes
- Joint pain, arthritis, or stiffness (musculoskeletal events are among the most frequent)
- Fatigue or weakness
- Nausea or vomiting
- Headache
- Bone loss (osteoporosis) and increased risk of fractures
- High blood pressure
- Depression, insomnia, or mood changes
- Swelling (peripheral edema or lymphedema)
Rarely (in fewer than 1 in 10,000 patients), serious reactions can occur: severe skin blistering or ulcers, significant allergic reactions with face or throat swelling, and liver function abnormalities with yellowing of the skin or eyes. Seek immediate medical attention if any of these occur.
⚠️Warnings & precautions▾
- Bone loss: Anastrozole reduces estrogen, which can decrease bone density and raise fracture risk — especially of the spine, hip, and wrist. Bone monitoring and protective measures (calcium, vitamin D, or bisphosphonates) may be recommended.
- Heart health: In women with pre-existing ischemic heart disease (reduced blood flow to the heart), anastrozole was associated with a higher rate of cardiac events compared to tamoxifen. Discuss your heart history with your doctor before starting.
- Cholesterol: Anastrozole may raise total cholesterol in some patients. Your doctor may monitor your lipid levels during treatment.
- Pregnancy: Anastrozole can seriously harm a developing baby. Women who could become pregnant must use effective contraception during treatment and for at least 3 weeks after the last dose. Do not breastfeed during treatment or for 2 weeks after stopping.
- Serious allergic reactions: Stop anastrozole and get emergency care if you develop swelling of the face, lips, tongue, or throat, or have difficulty breathing.
🔀What it interacts with▾
Anastrozole has a few important drug interactions to be aware of:
- Tamoxifen: Do not take these two drugs together. Combining them reduces anastrozole's blood levels and provides no added benefit over tamoxifen alone.
- Estrogen-containing products (e.g., hormone replacement therapy, estrogen pills or patches): These can directly counteract anastrozole's cancer-fighting action and should be avoided.
- Warfarin: Anastrozole does not appear to meaningfully alter warfarin's levels or anticoagulant effect, but always inform your prescriber and pharmacist of all medications you take.
- Cytochrome P450 enzyme interactions: Based on lab and human studies, anastrozole is unlikely to significantly affect other drugs through liver enzyme pathways at the standard dose.
This is not a complete list of interactions. Always talk with your doctor or pharmacist before starting, stopping, or changing any medication.
📋Before taking it▾
- Pregnancy: Anastrozole must not be used during pregnancy — it can cause serious harm or loss of the pregnancy. Pregnancy status should be confirmed before starting treatment in women of reproductive potential.
- Premenopausal women: Anastrozole is contraindicated in premenopausal women, including those who are or may become pregnant — it offers no clinical benefit and poses fetal risk.
- Breastfeeding: Do not breastfeed while taking anastrozole or for 2 weeks after the last dose.
- Allergy: Do not take anastrozole if you have had a hypersensitivity reaction (such as anaphylaxis, severe swelling, or hives) to anastrozole or any of its ingredients.
- Heart disease: Women with pre-existing ischemic heart disease should discuss risks carefully with their doctor before starting.
- Liver impairment: Mild-to-moderate liver disease does not require a dose change; severe liver impairment has not been studied.
- Kidney impairment: No dose adjustment is needed, even with significant kidney disease.
- Children and adolescents: Anastrozole's efficacy has not been demonstrated for adolescent boys with gynecomastia or girls with McCune-Albright Syndrome; it is not a proven treatment in these groups.
🚑If you take too much▾
No single dose of anastrozole that causes life-threatening symptoms has been identified in clinical studies. There is no specific antidote — treatment focuses on supportive care, monitoring vital signs, and managing symptoms. If an overdose is suspected, seek medical attention promptly; inducing vomiting may be considered if the person is alert, and dialysis may help since anastrozole is not highly bound to blood proteins.
📡Pharmacodynamics — effects in the body▾
Anastrozole significantly lowers the amount of estradiol (the main active estrogen) circulating in the blood. At the standard daily dose, estradiol levels drop by about 70% within the first 24 hours and by roughly 80% after two weeks of consistent use. This suppression is maintained for up to six days after stopping daily dosing. Anastrozole does not affect the body's production of cortisol, aldosterone, or thyroid-stimulating hormone, meaning it does not disrupt the adrenal or thyroid systems.
🔬Pharmacokinetics — how your body processes it▾
Anastrozole is rapidly absorbed after an oral dose, reaching peak blood levels in about 2 hours on an empty stomach (food delays this to about 5 hours but does not reduce the total amount absorbed). It has a long half-life of approximately 50 hours, meaning it stays active in the body for several days — blood levels reach a stable, steady state after about 7 days of once-daily dosing. The drug is broken down mainly by the liver (about 85% of elimination), with a small portion removed by the kidneys; no dose adjustment is needed for kidney or mild-to-moderate liver impairment.
📦How to store it▾
Store at controlled room temperature, 20° to 25°C (68° to 77°F) . Dispense in a tight, light-resistant container as defined in the USP, with a child-resistant closure (as required).
📄 Written from Anastrozole’s FDA-approved label information, summarized in plain language with AI, and reviewed by our pharmacy team before publication. Every point is grounded in that labeling — nothing is invented. How we use AI →
Supplements & herbs that interact with Anastrozole
22 supplements and herbal products have documented interactions with Anastrozole in the licensed clinical database we use. Most are manageable — but your pharmacist should know about everything you take, including vitamins and herbals.
- Major · 1
- Moderate · 12
- Minor · 9
Educational information from a licensed clinical database (Natural Medicines) — see our data sources & update cadence. Not medical advice: an interaction being documented does not mean it will happen to you; do not start or stop medications or supplements without professional guidance.
🩺 Pharmacist Counseling Corner
Quick, plain-English answers to the questions patients ask most about Anastrozole — the kind of thing our pharmacy team would talk through with you at the counter.
What exactly is anastrozole doing in my body to fight breast cancer? ▾
Can I take anastrozole with food, or does it have to be on an empty stomach? ▾
My joints have been really achy since I started anastrozole. Is that normal, and will it go away? ▾
I heard anastrozole can weaken my bones. What should I be doing about that? ▾
Can I take anastrozole with tamoxifen or with my hormone replacement therapy? ▾
Is anastrozole safe to take if I'm thinking about becoming pregnant or if I'm breastfeeding? ▾
Is Anastrozole available over the counter? ▾
When was Anastrozole first available? ▾
Who makes Anastrozole? ▾
💬 Answers drafted from Anastrozole’s FDA-approved label information, summarized in plain language with AI, and reviewed by our pharmacy team before publication. Grounded in that labeling — nothing is made up. How we use AI →
🧰 Keep exploring
💊 How Anastrozole comes
Anastrozole is available in 2 forms. Different forms and brands can have different approved uses, doses, schedules, and directions. Follow the instructions for your exact product, and do not switch forms without guidance from your prescriber or pharmacist.
Tablet
How this form is used
- Arimidex (tablet) is used for adjuvant treatment of postmenopausal women with hormone receptor-positive early breast cancer
- Arimidex (tablet) is used as first-line treatment of postmenopausal women with hormone receptor-positive or hormone receptor-unknown locally advanced or metastatic breast cancer
- Arimidex (tablet) is used for advanced breast cancer in postmenopausal women whose disease progressed after tamoxifen therapy
- Anastrozole (tablet) is indicated for the same three breast cancer uses as Arimidex in postmenopausal women
- Arimidex and Anastrozole tablets are each taken once daily by mouth
- Both Arimidex and Anastrozole tablets may be taken with or without food
- For advanced breast cancer, Arimidex and Anastrozole tablets should be continued until tumor progression, as directed by your prescriber
- No dose adjustment is needed for kidney problems or older age; patients with mild-to-moderate liver disease also require no dose change
Oral suspension
📊 Anastrozole across the U.S. market
How Anastrozole appears in the FDA’s National Drug Code Directory — including its dosage forms, strengths, brand names, manufacturers, and FDA-listed product records. These are directory records, not sales or prescription volume.
FDA-listed product records by dose form (tablet variants merged) — FDA National Drug Code Directory. Record counts are not sales or prescription volume.
Also listed with the FDA, not a patient dose form: Powder (25) — bulk drug substance sold to compounders/manufacturers and multi-item kits. These aren’t counted in the dose-form total above.
Share of FDA-listed product records by manufacturer — FDA National Drug Code Directory. Record counts are not sales or prescription volume.
📈 How widely Anastrozole is used
A general measure of how commonly Anastrozole is prescribed, based on Medicaid — one of the largest public drug programs. The figure below is prescriptions filled in Q1–Q4 2025, summed across every form and brand of the drug.
Think of this as a proxy for how widely Anastrozole is used, drawn from freely available public data. Medicaid is just one program — these numbers don’t include Medicare, other government coverage, or commercial and cash-pay prescriptions, so real-world use is higher than what’s shown here.
How commonly is Anastrozole prescribed? Of the 1,596 medications we measure, Anastrozole ranks #378 by Medicaid prescriptions — more than 76% of them.
Utilization by Anastrozole product
Pick a product to see its own Medicaid numbers. Each chip is one clinical product — a specific strength & dosage form as defined by RxNorm — with brand-name and generic versions combined.
anastrozole 1 MG Oral Tablet
Summed across the 17 of 127 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 199224
Shares are of the Medicaid prescriptions shown here. Product grouping follows RxNorm (the National Library of Medicine’s drug terminology), so “one product” means one strength & dosage form regardless of manufacturer. Dollar figures are gross Medicaid reimbursement before mandatory rebates — rebates (often large, especially for brand-name drugs) are confidential, so actual net cost to Medicaid is lower than shown.
Source: Medicaid State Drug Utilization Data (CMS), aggregated by generic ingredient — summed across every NDC (all brands, strengths, salt forms and dosage forms) of Anastrozole, and across all states and both fee-for-service and managed-care claims. A general popularity signal; it excludes Medicare, commercial insurance and cash prescriptions, so it is not total U.S. use. Based on the 17 of 127 listed Anastrozole NDCs with Medicaid activity.
🔍 Compare Anastrozole products
A representative set of FDA-listed product records for Anastrozole — across manufacturers, strengths, and dosage forms, grouped by form with each product’s manufacturer and how the FDA approved it. The same medicine may be made and packaged by different companies, so a single drug can have many directory entries. (It’s also why a refill can look different — a new shape, color, or box — even though it contains the same medication.)
| Strength | Route | Manufacturer / Labeler | Category ⓘ | Details |
|---|---|---|---|---|
| 💊Oral suspension | ||||
| 1 kg/kg | — | Sichuan Xieli Pharmaceutical Co., Ltd. | BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING | View NDC → |
| 💊Tablet | ||||
| 1 mg | Oral | A-S Medication Solutions × 7 listings | ANDA | View NDC → |
| 1 mg | Oral | Accord Healthcare Inc. × 3 listings | ANDA | View NDC → |
| 1 mg | Oral | American Health Packaging × 3 listings | ANDA | View NDC → |
| 1 mg | Oral | ANI Pharmaceuticals, Inc. × 3 listings | NDA | View NDC → |
| 1 mg | Oral | Asclemed USA, Inc. × 2 listings | ANDA | View NDC → |
| 1 mg | Oral | Asclemed Usa Inc. | ANDA | View NDC → |
| 1 mg | — | AstraZeneca Pharmaceuticals LP | DRUG FOR FURTHER PROCESSING | View NDC → |
| 1 mg | Oral | Aurobindo Pharma Limited × 2 listings | ANDA | View NDC → |
| 1 mg | Oral | Avet Pharmaceuticals Inc × 2 listings | ANDA | View NDC → |
| 1 mg | Oral | AvKARE × 5 listings | ANDA | View NDC → |
| 1 mg | Oral | AvPAK × 3 listings | ANDA | View NDC → |
| 1 mg | Oral | BluePoint Laboratories × 3 listings | ANDA | View NDC → |
| 1 mg | Oral | Breckenridge Pharmaceutical, Inc. × 5 listings | ANDA | View NDC → |
| 1 mg | Oral | Bryant Ranch Prepack × 8 listings | ANDA | View NDC → |
| 1 mg | Oral | Chartwell RX, LLC × 3 listings | ANDA | View NDC → |
| 1 mg | Oral | Denton Pharma, Inc. DBA Northwind Pharmaceuticals | ANDA | Find on DailyMed ↗ |
| 1 mg | Oral | Direct_Rx × 3 listings | ANDA | View NDC → |
| 1 mg | Oral | Major Pharmaceuticals | ANDA | View NDC → |
| 1 mg | Oral | Natco Pharma Limited | ANDA | View NDC → |
| 1 mg | Oral | NuCare Pharmaceuticals, Inc. × 2 listings | ANDA | View NDC → |
| 1 mg | Oral | NuCare Pharmaceuticals,Inc. × 11 listings | ANDA | View NDC → |
| 1 mg | Oral | PD-Rx Pharmaceuticals, Inc. × 12 listings | ANDA | View NDC → |
| 1 mg | Oral | Proficient Rx LP × 3 listings | ANDA | View NDC → |
| 1 mg | Oral | Remedyrepack Inc. × 2 listings | ANDA | Find on DailyMed ↗ |
| 1 mg | Oral | Rising Pharmaceuticals, Inc. | ANDA | View NDC → |
| 1 mg | Oral | Teva Pharmaceuticals USA, Inc. × 3 listings | ANDA | View NDC → |
| 1 mg | Oral | Upsher-Smith Laboratories, LLC | ANDA | View NDC → |
| 1 mg | Oral | Yiling Pharmaceutical, Inc. × 3 listings | ANDA | View NDC → |
| 1 mg | Oral | Zydus Lifesciences Limited × 2 listings | ANDA | View NDC → |
| 1 mg | Oral | Zydus Pharmaceuticals USA Inc. × 3 listings | ANDA | View NDC → |
| 💊Bulk drug substance | ||||
| 24.75 g/25 g | — | AX Pharmaceutical Corp | BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING | View NDC → |
| 1 kg | — | Catalent Micron Technologies, Inc. | DRUG FOR FURTHER PROCESSING | View NDC → |
| 5 g/5 g | — | Darmerica, Llc | BULK INGREDIENT | View NDC → |
| 1 kg/kg | — | Dr.Reddy's Laboratories Limited | BULK INGREDIENT | View NDC → |
| 1 kg/kg | — | Excella GmbH & Co. KG × 6 listings | BULK INGREDIENT | View NDC → |
| 1 kg/kg | — | Hetero Labs Limited | BULK INGREDIENT | View NDC → |
| 1 g/g | — | Letco Medical, Llc × 2 listings | BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING | View NDC → |
| 1 g/g | — | MEDISCA Inc. | BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING | View NDC → |
| 1 kg/kg | — | Natco Pharma Limited | BULK INGREDIENT | View NDC → |
| 100 g/100 g | — | Pharma Source Direct, Inc. | BULK INGREDIENT | View NDC → |
| 1 kg/kg | — | Professional Compounding Centers of America | BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING | View NDC → |
| 5 kg/5 kg | — | Professional Compounding Centers of America dba PCCA | BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING | View NDC → |
| 1 g/g | — | Qingdao Biopeptek Co., Ltd. | BULK INGREDIENT | View NDC → |
| 1 kg/kg | — | ScinoPharm Taiwan Ltd. | BULK INGREDIENT | View NDC → |
| 5 kg/5 kg | — | Sun Pharmaceutical Industries, Inc. | BULK INGREDIENT | View NDC → |
| 1 kg/kg | — | Synthimed Labs Private Limited | BULK INGREDIENT | View NDC → |
| 1 kg/kg | — | WanYang Hengshui Pharmaceutical Co., Ltd | BULK INGREDIENT | View NDC → |
| 100 g/100 g | — | Zhejiang Haizhou Pharmaceutical Co., Ltd. | BULK INGREDIENT | View NDC → |
| 1 kg/kg | — | Zhejiang Hisun Pharmaceutical Co., Ltd. | BULK INGREDIENT | View NDC → |
Showing 126 of 126 products — FDA National Drug Code Directory. See every product, package size and price: browse all 126 Anastrozole NDCs →
📈 What people report — real-world data (FDA FAERS)
After a medicine reaches the market, patients, doctors and drugmakers can send the FDA reports of problems they think may be linked to it. Here’s what’s been reported for Anastrozole — a signal of what to watch for, not proof the drug caused it.
Source: openFDA, from the FDA Adverse Event Reporting System (FAERS). These are voluntary reports — they don’t prove the drug caused the effect, and counts reflect how often something was reported, not how often it actually happens. Reports also often name the very problem the medicine is taken for — a common reason to file one is that the drug didn’t help — so for a pain reliever you may see “pain” high on the list; that points to why the report was filed, not to the drug causing the symptom. This counts every report that lists Anastrozole in any role, so the total runs higher than the FDA’s official dashboard, which counts only cases where the drug is the suspect. For the authoritative figures, see the FDA FAERS Public Dashboard. Always talk to your pharmacist or doctor.
🏛️ The road to your pharmacy
How Anastrozole went from FDA review to the pharmacy shelf — the key milestones in its regulatory journey.
Source: Drugs@FDA.
🚨 Recall history
A recall is when a specific batch of a medicine is pulled from the market — usually a manufacturing issue, not a problem with the drug itself. Class I is most serious, Class III least.
Source: openFDA drug enforcement (recall) reports.
RxNorm Concept Web — From Ingredient to Every Form and Strength
This page starts with one ingredient concept (IN). The branches below show its dose-form concepts (SCDF), then the available clinical drug and strength concepts (SCD). Combination products remain separate concepts with their own pages.
RxCUI 84857 1 dose form · 1 strength
-
Dose form (SCDF) Oral Tablet RxCUI 370588In current FDA listingsClinical drug / strength (SCD) 1 MGRxCUI 199224
Look up RxCUI 84857 in the RxCUI Atlas →
RxNorm is the U.S. National Library of Medicine’s normalized drug vocabulary. Its concept hierarchy can include forms that are not currently marketed; the status on each branch compares that concept with current FDA listings. RxCUIs identify vocabulary concepts, not individual packages or manufacturers.
📦 Supply & shortage status
Whether Anastrozole is in short supply in the U.S. right now, plus any shortage history the FDA has on record. A shortage usually reflects a manufacturing or demand issue — not a safety problem with the drug.
Source: openFDA, from the FDA Drug Shortages database.
🏷️ Sold under these brand names
🏭 Manufacturers & labelers
…and 16 more on the FDA NDC directory.
RxNorm drug class
Anastrozole belongs to the Aromatase Inhibitor class.
Classified by RxNorm RxClass — the U.S. National Library of Medicine's standardized drug-classification service (Established Pharmacologic Class from the FDA, the ATC drug family from the WHO, and mechanism of action). Reference only, not medical advice.
🔬 Where this comes from
Core label, product, RxNorm, safety, and utilization data on this page come from the sources identified below. AI-written, editorial, and licensed sections are labeled separately.
How we combine label and product data
HelloPharmacist combines public FDA and NLM records; we don’t author the underlying clinical facts. We identified 40 FDA-filed SPL label sets within the page’s selected clinical scope after exact ingredient or ingredient-combination matching and applicable route/form matching. The representative label is the starting point for the displayed reference monograph; the 12 largest stored in-scope SPL records, which may include that representative, are compared section by section, and the longest available version of each section is retained. Forms, routes, brands, labelers, product-listed strengths, and product-record counts are aggregated separately from ingredient-matched FDA NDC Directory records; package records listed above are associated with the linked SPL; and the normalized concept hierarchy comes from NLM RxNorm.
For canonical ingredient pages, bounded product-attributed indication and administration excerpts may be added to the AI evidence, and the generator is instructed to preserve available product, brand, route, and form qualifiers instead of treating one label as universal. Where a section is identified as AI-written, its plain-language text is generated from bounded label evidence. New draft drug pages remain in the admin review queue before first publication. ANI Pharmaceuticals, Inc. is the representative DailyMed label linked for verification and dates; it is not the sole source used for the page.
This is general education, not medical advice — always consult your doctor or pharmacist about your medications and any medical condition. For the exact wording of the linked representative label, view that label on DailyMed; some displayed composite sections may come from other in-scope SPL labels. Learn how we use AI and our data sources & update cadence.